2024
PO0222 Feasibility of 3-D Printed Prototypes of Indwelling Intrauterine Tube for Tandem-Based Cervical Brachytherapy
Tien C, Damast S, Glennon A. PO0222 Feasibility of 3-D Printed Prototypes of Indwelling Intrauterine Tube for Tandem-Based Cervical Brachytherapy. Brachytherapy 2024, 23: s105. DOI: 10.1016/j.brachy.2024.08.156.Peer-Reviewed Original ResearchSmit sleeveIntrauterine tubeCervical brachytherapyAnimal modelsClinical useUtero timeCT imagesBeam radiationPrevent perforationBrachytherapyClinical prototypeIn-house methodologyClinicMinutesImplantationSTL fileSleeveCervixIntrauterineDaysUterusUteroLong-termCoefficient of thermal expansionISO tests
2019
Outcomes of FIGO 2009 stage IB grade 2 or 3 endometrioid endometrial adenocarcinoma treated with adjuvant vaginal brachytherapy following comprehensive surgical staging
Hochreiter A, Kelly J, Young M, Litkouhi B, Black J, Stromberger C, Higgins S, Schwartz P, Damast S. Outcomes of FIGO 2009 stage IB grade 2 or 3 endometrioid endometrial adenocarcinoma treated with adjuvant vaginal brachytherapy following comprehensive surgical staging. Gynecologic Oncology 2019, 154: 287. DOI: 10.1016/j.ygyno.2019.04.674.Peer-Reviewed Original Research
2018
Extended duration of dilator use beyond 1 year may reduce vaginal stenosis after intravaginal high-dose-rate brachytherapy
Stahl JM, Qian JM, Tien CJ, Carlson DJ, Chen Z, Ratner ES, Park HS, Damast S. Extended duration of dilator use beyond 1 year may reduce vaginal stenosis after intravaginal high-dose-rate brachytherapy. Supportive Care In Cancer 2018, 27: 1425-1433. PMID: 30187220, DOI: 10.1007/s00520-018-4441-5.Peer-Reviewed Original ResearchConceptsVaginal stenosisEndometrial carcinomaMultivariable Cox proportional hazardsMultivariable Cox regression analysisVD useAcademic tertiary referral centerTertiary referral centerCox regression analysisLog-rank testCox proportional hazardsDevelopment of gradeDilator usePelvic radiotherapyReferral centerNoncompliant patientsPrimary outcomeAdjuvant brachytherapyEC patientsConclusionsThe riskRate brachytherapyProportional hazardsOptimal durationPatientsBrachytherapyStudy period
2017
Cost-Effectiveness of Adjuvant Intravaginal Brachytherapy in High-Intermediate Risk Early Stage Endometrial Carcinoma
Stahl J, Lester-Coll N, Bledsoe T, An Y, Damast S. Cost-Effectiveness of Adjuvant Intravaginal Brachytherapy in High-Intermediate Risk Early Stage Endometrial Carcinoma. International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e416. DOI: 10.1016/j.ijrobp.2017.06.1597.Peer-Reviewed Original Research
2014
Predictors of Vaginal Stenosis Following Intra-vaginal High-Dose-Rate Brachytherapy for Endometrial Carcinoma
Park H, Ratner E, Lucarelli L, Polizzi S, Higgins S, Damast S. Predictors of Vaginal Stenosis Following Intra-vaginal High-Dose-Rate Brachytherapy for Endometrial Carcinoma. International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s111. DOI: 10.1016/j.ijrobp.2014.05.532.Peer-Reviewed Original Research